Geulah Livshits

Stock Analyst at Chardan Capital

(1.39)
# 1924
Out of 5,441 analysts
241
Total ratings
Success rate
Average return
35 Stocks
Name Action PT Current % Upside Ratings Updated
PVLA Palvella Therapeutic...
Maintains: Strong Buy
50 60
41.54 44.44% 2 Aug 15, 2025
IMRX Immuneering
Maintains: Buy
13 13
3.23 302.48% 13 Aug 14, 2025
SLDB Solid Biosciences
Maintains: Buy
15 15
6.06 147.52% 8 Aug 14, 2025
TSHA Taysha Gene Therapie...
Maintains: Strong Buy
9 10
2.75 263.64% 14 Aug 12, 2025
FDMT 4D Molecular Therape...
Maintains: Buy
25 25
5.53 352.08% 12 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
68 60
10.75 458.14% 15 Aug 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 11
2.93 275.43% 20 Aug 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 10
3.51 184.9% 6 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 12
1.51 694.7% 10 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 20
1.97 915.23% 14 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
0.68 1223.53% 12 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
82 82
55.44 47.91% 15 Aug 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
219 219
137.58 59.18% 12 Aug 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
120 120
5.92 1927.03% 5 Jun 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 6
0.49 1124.49% 6 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 12
1.81 562.98% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
22 20
4.44 350.45% 9 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 10 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 6
1.48 305.41% 5 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
41 41
7.83 423.63% 4 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 25
6.34 294.32% 2 Mar 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12
1.32 809.09% 4 Mar 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 25
24.98 0.08% 4 Mar 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
191 208
25.48 716.33% 7 Jan 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
160 40
n/a n/a 3 Dec 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 16
1.1 1354.55% 4 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
7.5 -66.67% 5 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
450 270
0.93 28932.26% 2 Feb 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
100 90
7.46 1106.43% 1 Nov 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 4
3.08 29.87% 3 Nov 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
3.2 525% 1 Oct 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
660 600
n/a n/a 2 Aug 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
50 30
2.23 1245.29% 1 Jul 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
9.66 86.34% 1 Oct 27, 2020